Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Br-PEG4-THP | C13H25BrO5 | 1803547-60-5 | Details |
| Fentiazac | C17H12ClNO2S | 18046-21-4 | Details |
| YNT-185 | C33H37N5O5S | 1804978-81-1 | Details |
| YNT-185 dihydrochloride | C33H38ClN5O5S | 1804978-82-2 | Details |
| FM04 | 1807320-40-6 | Details |
| IACS-010759 hydrochloride | C25H26ClF3N6O4S | 1807523-99-4 | Details |
| TBDMS-PEG4-Acid | C15H32O6Si | 1807540-77-7 | Details |
| CJJ300 | C30H33N3 | 1807631-83-9 | Details |
| Gedivumab | 1807954-17-1 | Details |
| Lesofavumab | 1807960-57-1 | Details |
| Gilvetmab | 1808081-43-7 | Details |
| Linvencorvir | C29H35FN6O5S | 1808248-05-6 | Details |
| Resomelagon | C14H14N6O2 | 1809420-71-0 | Details |
| NS1-IN-1 | C23H26N2O4 | 181373-35-3 | Details |
| NTRC 0066-0 | C33H39N7O2 | 1817791-73-3 | Details |
| TAK-418 | 1818252-53-7 | Details |
| Anticonvulsant agent 10 HCl | 1818253-48-3 | Details |
| Cis-22a | C24H30F3N3O2 | 1819366-84-1 | Details |
| GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
| Lorundrostat | C24H33N7O2 | 1820940-17-7 | Details |
| ZY-19489 | C24H32FN9 | 1821293-40-6 | Details |
| Tinlarebant | C21H21F5N4O2 | 1821327-95-0 | Details |
| N-Nitroso-N-methylaniline-d5 | C7H8N2O | 1821341-18-7 | Details |
| BRD2492 | C20H18N4O2 | 1821669-43-5 | Details |
| SMO-IN-2 | C25H25F4N5O2 | 1822355-27-0 | Details |
| SDH-IN-2 | C10H6F3NO | 1823354-06-8 | Details |
| Acloproxalap | C12H14N2O | 1824609-67-7 | Details |
| TRV-120027 acetate (1234510-46-3 free base) | 1824712-70-0 | Details |
| CXCR2 antagonist 8 | C14H13N3O5 | 182498-30-2 | Details |
| Smurf-1 modulator CMP Example 20 | C23H34N4O5 | 1825371-51-4 | Details |
| Gatralimab | 1826020-80-7 | Details |
| Azintuxizumab | 1826819-57-1 | Details |
| Talacotuzumab | 1826831-79-1 | Details |
| cPrPMEDAP | C11H17N6O4P | 182798-83-0 | Details |
| Clenoliximab | 182912-58-9 | Details |
| Idelalisib D5 | C22H18FN7O | 1830330-31-8 | Details |
| Duvortuxizumab | 1831098-91-9 | Details |
| Lacnotuzumab | 1831128-32-5 | Details |
| MLT-985 | C17H15Cl2N9O2 | 1832576-25-6 | Details |
| L-161240 | C15H20N2O5 | 183298-68-2 | Details |
| Gantofiban | C21H29N5O6 | 183547-57-1 | Details |
| EGFR-IN-87 | C28H33N7O2 | 1835666-87-9 | Details |
| Rezivertinib | C27H30N6O3 | 1835667-12-3 | Details |
| AY 77 | C21H32N4O4 | 1835734-92-3 | Details |
| CXCR2-IN-2 | C18H23ClN2O5S | 1838123-21-9 | Details |
| NS-2710 | C22H20N4O | 184220-36-8 | Details |
| NBI-27914 | C18H20Cl4N4 | 184241-44-9 | Details |
| Cofrogliptin | C18H19F5N4O3S | 1844874-26-5 | Details |
| (Iso)-Rilmakalim | 184653-89-2 | Details |
| Diprogulic acid | C12H18O7 | 18467-77-1 | Details |
| Setrusumab | 1847394-95-9 | Details |
| Tibulizumab | 1849636-24-3 | Details |
| Zavondemstat | C26H29N3O3 | 1851412-93-5 | Details |
| PF-06649298 | C16H22O5 | 1854061-16-7 | Details |
| PF-06761281 | C13H17NO6 | 1854061-19-0 | Details |
| Trifluoromethyl-tubercidin | C12H13F3N4O4 | 1854086-05-7 | Details |
| Iruplinalkib | C29H38ClN6O2P | 1854943-32-0 | Details |
| Cibisatamab | 1855925-27-7 | Details |
| Tislelizumab | 1858168-59-8 | Details |
| Basroparib | C18H21F2N7O3 | 1858179-75-5 | Details |
| Edralbrutinib | C26H21F2N5O3 | 1858206-58-2 | Details |
| (3S,4S)-PF-06459988 | C19H22ClN7O3 | 1858291-14-1 | Details |
| Tofimilast | C18H21N5S | 185954-27-2 | Details |
| Tyrosinase-IN-12 | C16H12ClN3S | 1860779-42-5 | Details |
| STC314 | C13H25NaO32S7 | 186295-19-2 | Details |
| hCYP3A4 Fluorogenic substrate 1 | C19H12FNO2 | 186299-00-3 | Details |
| PF-06737007 | C25H28F4N2O6 | 1863905-38-7 | Details |
| SU 5616 | C13H8ClNOS | 186611-58-5 | Details |
| TriGalNAc CBz | C34H35NO11 | 186613-57-0 | Details |
| Berberine ursodeoxycholate | 1868138-66-2 | Details |
| Cofetuzumab | 1869928-62-0 | Details |
| (R)-CJ 11974 | 187281-35-2 | Details |
| Loncastuximab | 1875032-68-0 | Details |
| Naxitamab | 1879925-92-4 | Details |
| FFN 206 dihydrochloride | C12H15ClN2O2 | 1883548-88-6 | Details |
| JTV-519 fumarate | C29H36N2O6S | 1883549-36-7 | Details |
| OPC-167832 | C21H20ClF3N2O4 | 1883747-71-4 | Details |
| Mirikizumab | 1884201-71-1 | Details |
| HDAC8-IN-20a | C15H15NO4 | 1884231-52-0 | Details |
| Cbz-B3A | C35H58N6O9 | 1884710-81-9 | Details |
| EM127 | C14H18ClN3O3 | 1886879-71-5 | Details |
| PB1 | 188714-28-5 | Details |
| EPZ032597 | C20H23N7O | 1887193-58-9 | Details |
| EPZ033294 | C20H22ClN7O | 1887195-17-6 | Details |
| Dersalazine | C35H32N6O4 | 188913-58-8 | Details |
| HS94 | C15H15N5O2S | 1892594-93-2 | Details |
| Tisolagiline | C17H17F3N2O | 1894207-44-3 | Details |
| Omburtamab | 1895083-75-6 | Details |
| MMPP | C17H18O3 | 1895957-18-2 | Details |
| Aplindore Fumarate | C22H22N2O7 | 189681-71-8 | Details |
| Zamaporvint | C21H16F3N7O | 1900754-56-4 | Details |
| Fmoc-aminooxy-PEG2-NH2 | C19H22N2O5 | 190249-87-7 | Details |
| 1,4-Dideoxy-1,4-epithio-D-ribitol | C5H10O3S | 190315-43-6 | Details |
| Mosunetuzumab | 1905409-39-3 | Details |
| Iladatuzumab | 1906205-76-2 | Details |
| Enapotamab | 1912423-61-0 | Details |
| Ursolic aldehyde | C30H48O2 | 19132-81-1 | Details |
| Propionic-2,2-d2 acid | C3H4D2O2 | 19136-91-5 | Details |
| 3-phenylpropanoic-2,2-d2 acid | C9H8D2O2 | 19136-97-1 | Details |
| Ezurpimtrostat hydrochloride | C25H32Cl2N4 | 1914148-73-4 | Details |
| Product Total： Product Page： | ||||
| 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||